Tag Archives: QIAGEN

The leading provider of molecular Sample to Insight solutions QIAGEN announces a major expansion of its digital PCR (dPCR) assay offerings

13 new kits and assays allow for quantification of AAV viral titer and residual host cell DNA in cell and gene therapy Custom assay design provides dPCR users with access to tailored multiplex assays for use beyond biopharma applications Milestone … Read the full press release

Le principal fournisseur de solutions moléculaires Sample to Insight QIAGEN annonce une expansion majeure de ses offres de tests PCR numériques (dPCR)

13 nouveaux kits et tests permettent de quantifier le titre viral d’AAV et l’ADN résiduel de la cellule hôte en thérapie cellulaire et génique La conception de tests personnalisés permet aux utilisateurs de dPCR d’accéder à des tests multiplex personnalisés … Read the full press release

QIAGEN, der führende Anbieter von molekularen Sample-to-Insight-Lösungen, kündigt eine bedeutende Erweiterung seines Angebots an digitalen PCR (dPCR)-Assays an

13 neue Kits und Tests ermöglichen die Quantifizierung von AAV-Titern und restlicher Wirtszell-DNA in der Zell- und Gentherapie Custom Assay Design Service bietet Nutzern von dPCR Zugang zu maßgeschneiderten Multiplex-Assays über den Einsatz in Biopharma-Anwendungen hinaus Meilenstein mit mehr als … Read the full press release

QIAGEN gibt neue Meilensteine für seinen Tuberkulose-Test QuantiFERON bekannt

HILDEN, Deutschland, GERMANTOWN, Maryland (USA), und SHANGHAI, China, 7-Feb-2022 — /EuropaWire/ — QIAGEN NV (NYSE: QGEN; Frankfurt Prime Standard: QIA), ein deutscher Anbieter von Sample-to-Insights-Lösungen, die es Kunden ermöglichen, Einblicke in die Bausteine des Lebens – DNA, RNA und Proteine … Read the full press release

QIAGEN annonce de nouvelles étapes pour son test de tuberculose QuantiFERON

(COMMUNIQUÉ DE PRESSE) HILDEN, Germany / GERMANTOWN, MD, United Staes / SHANGHAI, 7-Feb-2022 — /EuropaWire/ — QIAGEN NV (NYSE : QGEN ; Frankfurt Prime Standard : QIA), une société allemande fournisseur de solutions Sample to Insights qui permettent aux clients de débloquer des informations sur … Read the full press release

QIAGEN announces new milestones for its QuantiFERON tuberculosis test

(PRESS RELEASE) HILDEN, Germany / GERMANTOWN, MD, United Staes / SHANGHAI, 7-Feb-2022 — /EuropaWire/ — QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a German provider of Sample to Insights solutions that enable customers to unlock insights from the building … Read the full press release

QIAGEN announces two new collaborations for its dPCR platform QIAcuity: Atila BioSystems and Actome

Expanding range of applications for growing base of QIAcuity digital PCR instruments Two new collaborations: Atila BioSystems expands menu to non-invasive prenatal testing (NIPT), while Actome partnership designed to enable for the first time protein analysis using digital PCR technology … Read the full press release

QIAGEN appoints Dr. Toralf Haag as a member of the Supervisory Board and the Audit Committee

(PRESS RELEASE) VENLO, the Netherlands, 8-Jan-2021 — /EuropaWire/ — QIAGEN announces the appointment of Dr. Toralf Haag as a member of the Supervisory Board with immediate effect. He will also become a member of the Audit Committee. Dr. Haag was … Read the full press release

QIAGEN Ergebnisse einer neuen Evaluierung im Bereich der Frauengesundheit die hohe Genauigkeit seiner Bioinformatik-Lösungen untermauern

Ergebnisse der Evaluierung der QCI-Plattform zur Interpretation klinisch relevanter Genvarianten werden auf der ASHG 2017 von Counsyl vorgestellt Orlando, Florida (USA), Germantown, Maryland (USA), und Hilden (Deutschland), 20-Oct-2017 — /EuropaWire/ — QIAGEN (NASDAQ: QGEN; Frankfurter Börse: QIA) gab heute bekannt, … Read the full press release

France’s Ministry of Health and Social Affairs approves reimbursement for QIAGEN’s QuantiFERON-TB® Gold Plus latent tuberculosis test

Gold-standard test for latent tuberculosis infection will be covered by national health insurance Hilden, Germany, and Paris, France, 23-Jun-2017 — /EuropaWire/ — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that France’s Ministry of Health and Social Affairs … Read the full press release

DiaSorin, QIAGEN to develop new tests for DiaSorin’s LIAISON family of analyzers

Saluggia, Italy; Hilden, Germany, and Germantown, Maryland, USA, 23-Jun-2017 — /EuropaWire/ — DiaSorin (FTSE Italy Mid Cap: DIA) and QIAGEN (NASDAQ: QGEN; Frankfurt Stock Exchange: QIA) announced today a new collaboration to develop new tests for DiaSorin’s LIAISON family of … Read the full press release

U.S. FDA premarket approval for QIAGEN’s automated artus® CMV QS-RGQ MDx kit for use on its QIAsymphony platform

High-throughput application of artus CMV QS-RGQ MDx Kit on QIAsymphony streamlines critical and frequently performed viral infection test for transplant patients Germantown, Maryland, and Hilden, Germany, 07-Jun-2017 — /EuropaWire/ — QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has … Read the full press release

QIAGEN receives worldwide license from The Johns Hopkins University for biomarkers for immune-oncology therapies in cancer treatment

Option to add new biomarkers for microsatellite instability (MSI) and mismatch repair (MMR) to QIAGEN’ s NGS panels Hilden, Germany, and Germantown, Maryland, 07-Jun-2017 — /EuropaWire/ — QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received a worldwide … Read the full press release

Bristol-Myers Squibb and QIAGEN to explore NGS technology to develop GEPs for I-O therapies in cancer treatment

NEW YORK and HILDEN, Germany, 06-Jun-2017 — /EuropaWire/ — Bristol-Myers Squibb Company (NYSE: BMY) and QIAGEN(NASDAQ: QGEN; Frankfurt Prime Standard: QIA) have signed an agreement to explore the use of next-generation sequencing (NGS) technology to develop gene expression profiles (GEPs) as  … Read the full press release

Evaluation affirms the performance of the QIAGEN’s GeneReader NGS System in detecting gene variants known to be clinically relevant in colorectal cancer

World’s first complete Sample to Insight NGS solution proves equal or better compared with other sequencing workflows and alternative technologies Austin, Texas, and Hilden, Germany, 6-11-2015 — /EuropaWire/ — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that an … Read the full press release

QIAGEN N.V. released Q2 and H1 2013 results and announced new share repurchase program

Q2 2013 results: Adjusted net sales of $316.4 million (+3% CER) on growth in all regions; adjusted operating income of $83.4 million; adjusted diluted EPS of $0.27 per shareNew program authorized to repurchase up to $100 million in QIAGEN shares … Read the full press release